haematology tutorial
TRANSCRIPT
![Page 1: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/1.jpg)
Haematology
![Page 2: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/2.jpg)
Aims of the session
• Brief overview of the haematological system• Leukaemias• Lymphomas• Myelomas and other paraproteinaemias• SBAs
![Page 3: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/3.jpg)
http://library.med.utah.edu/WebPath/webpath.html
Webpath•SBAs•Tutorials•Images•Covers most major systems of the body
![Page 4: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/4.jpg)
OSCE Scenario
• You are a GP and a 23-year old woman comes to visit your clinic complaining of decreased energy levels. Please take a history and attempt to formulate an appropriate management plan
(5 minutes)
![Page 5: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/5.jpg)
Key Differentials - TATT
• Hypothyroidism• Infection• Menorrhagia• Lyphoma• Other Malignancies
NB: DON’T FORGET: 1) General Proforma 2) Systemic Symptoms 3) ICE
![Page 6: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/6.jpg)
Terminally differentiated cells vs Partially differentiated
Hematopoiesis
![Page 7: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/7.jpg)
Some definitions
• Blast cell
• Terminally differentiated
• Totipotent stem cell
![Page 8: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/8.jpg)
Some definitions
• Blast cell – immature precursors of either lymphocytes (lymphoblasts) or myeloid cells (myeloblasts). They do not normally appear in peripheral blood. They can be recognized by their large size, and primitive nuclei (ie. the nuclei contain nucleoli).
• Terminally differentiated - cells which have specialized properties and functions. They are also unable to undergo cellular growth or multiplication.
• Totipotent stem cell – a cell that is capable of developing into any cell type including extraembyronic tissue.
![Page 9: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/9.jpg)
Terminally differentiated cells vs Blast cells
Terminally differentiated Blast cellsUnlikely to transform to other cell types
Slow rate of cell turnover (tumours of terminally differentiated cells will take time to accumulate – chronic leukaemias
Low cell turnover means they are less responsive to chemotherapyHighly specialized cell
Ability to transform to many cell types
Rapidly replicating (tumours of blast cells can accumulate quickly causing aacute leukaemias)
High cell turnover means they are more responsive to chemotherapyNot very specialized
![Page 10: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/10.jpg)
• Pluripotent stem cell
• Granulocyte
• Pancytopenia
![Page 11: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/11.jpg)
• Pluripotent stem cell – a cell which has the ability to differentiate into more than one cell type. Pluripotent stem cells are derived from totipotent stem cells. Pluripotent stem cells can develop into any cell type except for the extraembryonic tissue.
• Granulocyte - a circulating white blood cell which has prominent granules in the cytoplasm and a nucleus of two or more lobes. They are derived from the myeloid lineage and including neutrophils, basophils and eosinophils
• Pancytopenia - a reduction in the number of red and white blood cells, as well as platelets. It occurs due to a problem with the bone marrow.
![Page 12: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/12.jpg)
![Page 13: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/13.jpg)
A B
Describe?
![Page 14: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/14.jpg)
Classification of Leukaemias
Classified according to the cell lineage that is affected ie. myeloid or lymphoid
Also classified according to speed of onset ie acute due to accumulation of blast cells or chronic due to accumulation of a terminally differentiated cell.
![Page 15: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/15.jpg)
Disorders of the myeloid lineage
![Page 16: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/16.jpg)
Terminally differentiated cells vs Partially differentiated
Acute myeloid leukaemias
![Page 17: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/17.jpg)
Terminally differentiated cells vs Partially differentiated
Acute myeloid leukaemias The myeloid stem cell can
differentiate into myeloid, monocytic, or erythroid cells, or into megakaryocytes
![Page 18: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/18.jpg)
Terminally differentiated cells vs Partially differentiated
Acute myeloid leukaemias The myeloid stem cell can
differentiate into myeloid, monocytic, or erythroid cells, or into megakaryocytes
Therefore, AML can be derived from myeloblasts (MI-M2), promyelocytes (M3), a mixture of myeloblasts and monoblasts (M4), monoblasts (M5), erythroblasts (M6), or megakaryoblasts (M7).
![Page 19: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/19.jpg)
Acute myeloid leukaemias
• Characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
• The most common acute leukemia affecting adults.
• Two classification systems – WHO and the FAB
• FAB classification still widely used and clinically important
![Page 20: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/20.jpg)
French American British (FAB) classification of AML
Classified based upon type of precursor / blast cell which is predominant
Type Name Cytogenetics Associated featuresM0 minimally differentiated acute myeloblastic leukemia M1 acute myeloblastic leukemia, without maturation Gum hypertrophy
M2 acute myeloblastic leukemia, with granulocytic maturation t(8;21)(q22;q12), t(6;9) Auer rods
M3 promyelocytic, or acute promyelocytic leukemia (APL) t(15;17) DIC and Auer rods
M4 acute myelomonocytic leukemia inv(16)(p13q22), del(16q)
M4eo myelomonocytic together with bone marrow eosinophilia inv(16), t(16;16) Eosinophilia
M5 acute monoblastic leukemia (M5a) or acute monocytic leukemia (M5b) del (11q), t(9;11), t(11;19) Hypokalemia
M6 acute erythroid leukemias, including erythroleukemia (M6a) and very rare pure erythroid leukemia (M6b)
M7 acute megakaryoblastic leukemia t(1;22) Downs syndrome
![Page 21: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/21.jpg)
AML BLOOD FILM – WHAT CAN BE SEEN?
![Page 22: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/22.jpg)
Bone marrow apsirate showing Auer rods
• Highly specific for AML subtypes M2 and M3
![Page 23: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/23.jpg)
AML – Presentation• Patients present with pancytopaenia due to a hypercellular bone marrow
– Symptoms of anaemia– Infections– Bleeding
Other signs: Splenomegaly, Hepatomegaly, Lymphadenopathy
• Death in 6-12 weeks if left untreated.
• Best initial test is blood smear– Blast cells present (blasts have occupied all of the bone marrow and are now spilling
over into the blood)– WCC can be low, normal or high
![Page 24: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/24.jpg)
Treatment of acute leukaemia
Supportive:
ProblemAnaemiaThrombocytopeniaDICInfection
Tumour lysis syndrome
Treatment
![Page 25: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/25.jpg)
Treatment of acute leukaemia
Supportive:
ProblemAnaemiaThrombocytopeniaDICInfection
Tumour lysis syndrome
TreatmentPacked RBCsPlatelets (if <10)FFP, cyroprecipitateAntibiotics, reverse barrier nursingAllopurinol/rasburicase
![Page 26: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/26.jpg)
Definitive treatment for AMLChemotherapy:• Induction 4-6w• Consolidation• Duanorubicin + Cytobarine
• Other • Add in all-trans-retinoic-acid (ATRA) in PML (M3) during induction• Monoclonal Ab• CNS radiotherapy• BM transplantation
![Page 27: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/27.jpg)
The importance of the t(15;17) translocation
• The t(15;17) translocation is associated with PML (M3) and produces a PML-RARα fusion protein which binds to the retinoic acid receptor element in the promoters of several myeloid-specific genes and inhibits myeloid differentiation
• Treatment with Retinoic acid thus stimulates cellular differentiation and has a big impact on the prognosis of PML
![Page 28: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/28.jpg)
Terminally differentiated cells vs Partially differentiated
Myeloproliferative disorders
![Page 29: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/29.jpg)
Myeloproliferative disorders• A group of disorders which are due to over proliferation
of terminally differentiated cells of the myeloid lineage.• Are classified according to whether they are
Philadelphia chromosome positive or negative.
• Have the ability to transfrom into an acute myeloid leukaemia
Philadelphia positive Philadelphia negativeChronic myeloid leukaemia Polycythemia rubra vera
Essential thrombocytosis Myelofibrosis
![Page 30: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/30.jpg)
PathophysiologyTwo classes of mutations may be required:
![Page 31: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/31.jpg)
Terminally differentiated cells vs Partially differentiated
Chronic myeloid leukaemias
![Page 32: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/32.jpg)
Stepped-up production of granulocytes and their precursors and failed apoptosis leads to insidious progression towards a blast crisis.
Epidemiology
•Incidence= 0.6-2/100,000•Can occur at any age but rare in children. Peak incidence at 40-60 •Less common than AML, CLL
Chronic myeloid leukaemia
![Page 33: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/33.jpg)
Pathophysiology95% involve t(9;22)(q34;q11) translocation, resulting in the Philadelphia chromosome. This forms a fusion gene- BCR-ABL1 with constitutively active tyrosine kinase activity.
![Page 34: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/34.jpg)
Usually asymptomatic!
•Examination-Splenomegaly- may be only feature at latent phase, massive later on
•Bloods-Anaemia- mild, worsens with progression-WBCs- extremely high-Smear- leukocytosis with granulocyte left-shift
Symptoms
![Page 35: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/35.jpg)
Leukocytosis, increased numbers of banded neutrophils
![Page 36: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/36.jpg)
![Page 37: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/37.jpg)
•Imatinib-Tyrosine kinase inhibitor, targets BCR-ABL1. Greatly increases 5 year survival compared to older drug therapies
-Initial treatment, continued indefinitely if optimal response.
Other:•Monoclonals•Surgery
-Splenectomy for splenomegaly or pancytopenia•Radiotherapy
-Pallative for bulky LN or splenomegaly
Treatment of CML
![Page 38: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/38.jpg)
Prognosis
• Median survival 5-6 years.• Chronic Accelerated Blast Transformation
![Page 39: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/39.jpg)
Terminally differentiated cells vs Partially differentiated
Polycythemia rubra vera
![Page 40: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/40.jpg)
• Clinical features– Night sweats– Hyperviscosity symptoms– Pruritus after a hot bath– Plethoric face– Splenomegaly– Haemorrhage– Hypertension– Gout
• Increased proliferation of erythrocytes, and sometimes thrombocytes. Rarely increased proliferation of granulocytes
![Page 41: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/41.jpg)
• Important lab features– Increased Hb, HCT, Red cell mass– Low serum EPO– Increased platelet count– JAK2 mutation in 95%
• Treatment– Venesection– Cytotoxic myelosuppression
• Hydroxyurea• Busulphan
INCREASED RISK OF DEVELOPING ACUTE MYELOID LEUKAEMIA
![Page 42: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/42.jpg)
Terminally differentiated cells vs Partially differentiated
Histiocytosis (too many dendritic cells and macrophages aka histiocytes)
![Page 43: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/43.jpg)
Terminally differentiated cells vs Partially differentiated
Mastocytosis (too many mast cells)
![Page 44: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/44.jpg)
Disorders of the lymphoid lineage
![Page 45: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/45.jpg)
Terminally differentiated cells vs Partially differentiated
Lymphoproliferative disorders
![Page 46: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/46.jpg)
Terminally differentiated cells vs Partially differentiated
Acute lymphoblastic leukaemias
![Page 47: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/47.jpg)
Acute lymphoblastic leukaemia
Also known as ‘lymphocytic’.
Presents acutely with a pancytopenia and hypercellular bone marrow.
Epidemiology
•Incidence = 1/50,000. Slight male predominance.•Commonest type of childhood leukaemia (70%)•Peak age 2-5 years, but later increase >50.•Prognosis is poor if <1 year of age or >10 years of age.
![Page 48: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/48.jpg)
PathophysiologyUNCONTROLLED PROLIFERATION
•Genetic Factors - dysregulation of proto-oncogene e.g. TEL-AML1 (25%).
• Environmental Factors – X Rays + DOWN’S
85% are derived from B-cell precursors.
-T-cell ALL
-B-cell ALL
![Page 49: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/49.jpg)
Findings specific for ALL•Examination
-Lymphadenopathy-Splenomegaly (10-20% presentation)-CNS signs- more likely
•Bloods-Anaemia- usually severe, signs present-WBCs- variable, usually neutropenia-Smear- smallish basophilic blasts, few granules, hand-mirror cells-Clotting- 10% ALL presents with DIC
•Imaging-Mediastinal mass in some T cell ALL
![Page 50: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/50.jpg)
Small basophilic blasts with few granules
![Page 51: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/51.jpg)
Treatment of acute leukaemiaSupportive:
ProblemAnaemiaThrombocytopeniaDICInfection
Tumour lysis syndromeCNS prophylaxis
TreatmentPacked RBCsPlatelets (if <10)FFP, cyroprecipitateAntibiotics, reverse barrier nursingAllopurinol/uricase
Intrathecal chemo e.g. methotrexate, cytarabine
![Page 52: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/52.jpg)
DefinitiveChemotherapy:•Induction 4-6w•Consolidation•Maintenance (ALL only) 1-2y
-Longer in boys
Other
•Monoclonal Ab•CNS radiotherapy•BM transplantation
•5 year survival -Children- 75%-Adults- 40%
![Page 53: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/53.jpg)
Terminally differentiated cells vs Partially differentiated
Chronic lymphoid leukaemia/ lymphoma
![Page 54: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/54.jpg)
98% develop from B cells.
Epidemiology
•Incidence = 4.2/100,000. Slight male predominance.•Most common form of leukaemia in the West•Usually >55, median age 72, rare <40.
![Page 55: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/55.jpg)
Pathophysiology
Largely unknown with no specific genetic abnormalities.
![Page 56: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/56.jpg)
Symptoms specific for CLL
![Page 57: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/57.jpg)
Symptoms specific for CLLUsually asymptomatic!• Examination
-Lymphadenopathy/splenomegaly present in late disease.
• Bloods-WBCs- extremely high-Smear- lymphocytosis with ‘smudge/basketball
cells’• Other
-Richter’s syndrome-Prolymphocytic transformation
![Page 58: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/58.jpg)
Smudge cells- destruction of fragile lymphocytes during smear
![Page 59: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/59.jpg)
Treatment of CLL
• Watchful waiting with regular monitoring• Chemotherapy. Indications:
– Severe systemic symptoms– Non-pred-responsive AI anaemia/thrombocytopenia– Progressive splenomegaly/lymphadenopathy– Increased WBC/reduced ‘doubling time’
• Surgery– -Splenectomy for splenomegaly or pancytopenia
• Radiotherapy– -Pallative for bulky LN or splenomegaly
![Page 60: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/60.jpg)
![Page 61: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/61.jpg)
![Page 62: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/62.jpg)
What is the difference between lymphoma and CLL
• Are part of a continuum of disease• Leukemia usually refers to a condition in which the
abnormal cells populate the blood• But lymphoma usually initially populates LN,
spleen etc. to form a tumour mass.
![Page 63: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/63.jpg)
![Page 64: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/64.jpg)
Hodgkin’s lymphoma
Originates from B cells in the germinal centres of lymphoid tissue and is characterised by orderly spread from one LN group to another.
Epidemiology
•Incidence = 2.2/100,000, 30% of all lymphoma•Bimodal distribution with peaks at 15-30 and >50 years•Slight male predominance
![Page 65: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/65.jpg)
Risk factors•Acquired
-HIV/AIDS- increases with CD4 count-Previous non-Hodgkin’s lymphoma-Autoimmune conditions
•Inherited-Immune defects-Family history of H/non-H lymphoma, CLL
![Page 66: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/66.jpg)
PathogenesisSome proliferation of malignant Reed-Sternberg cells (probably of B cell lineage) and abnormal mononucleocytes.
![Page 67: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/67.jpg)
Presentation•Painless non-tender rubbery enlarged LN
-Cervical involvement in 60-70%, axillary in 10-15%, inguinal in 6-12%-May increase/decrease in size spontaneously-May become ‘matted’ and non-mobile-Contiguous progression to nearby groups-Alcohol-induced pain
•Systemic symptoms-Especially fever (30%), may be cyclic-And severe pruritis (25%)
•Other-Early satiety due to splenomegaly
![Page 68: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/68.jpg)
Investigations•FBC
-Exclude leukaemia, mononucleosis•ESR/CRP•LFTs•U&Es•CXR
-Lymphadenopathy, mediastinal expansion•CT
-Thorax, abdomen for staging•BM biopsy•Other
-HIV, Monospot, LDH, thoracentesis, PET, LP, MRI
![Page 69: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/69.jpg)
![Page 70: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/70.jpg)
Ann-Arbour staging
Automatic stage IV if extranodal involvement. Systemic symptoms = B, extranodal = E, >10cm = X, splenic involvement = S
![Page 71: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/71.jpg)
TreatmentSupportive•Fertility•Cardiac function•Respiratory function•Tumour lysis syndrome•Others, as indicated (see leukaemias slide)
![Page 72: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/72.jpg)
TreatmentDefinitive•IA/IIA
-Radiotherapy alone- affected nodes and prophylatically -Chemo with radiotherapy of affected nodes
•IB/IIB/III/IV-Chemo
•BM transplant-If still progressive despite chemo or after induction of remission after relapse
![Page 73: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/73.jpg)
Non-Hodgkin’s lymphoma
A heterogeneous group of lymphoid tumours, mostly of B cell origin. Characterised by irregular pattern of spread and common extranodal disease, they vary in their aggressiveness.
Epidemiology•Incidence = 17/100,000•Median age is >50•Diffuse large B cell and follicular commonest
![Page 74: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/74.jpg)
Risk factors•Acquired
-Infection e.g. EBV (Burkitt’s), HTLV-1 (T cell), HCV, HHV8 (Castleman’s), H. pylori (gastric MALT)-Previous chemotherapy/Hodgkin’s-Autoimmune disorders e.g. Sjogren’s, Hashimoto’s, coeliac-Immunodeficiency e.g. post-transplant, HIV/AIDS
•Inherited
![Page 75: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/75.jpg)
Pathogenesis
![Page 76: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/76.jpg)
Presentation•Painless non-tender rubbery enlarged LN
-Non-contiguous progression•Systemic symptoms
-Commoner in high-grade•Rash
-Cutaneous involvement e.g. mycosis fungoides, anaplastic large-cell etc.
•Abdominal pain, early satiety -Splenomegaly but unusual as rarely massive-Hepatomegaly
•Mass-Testicular-GI, symptoms of obstruction
•Shortness of breath, pleuritic chest pain, SVC syndrome-Mediastinal mass in high grade
•Neurological-Primary CNS lymphoma, commoner in immunosuppressed
![Page 77: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/77.jpg)
Investigations•FBC
-Anaemia, thrombocytopenia, neutropenia-Thrombocytosis, lymphocytosis may occur
•ESR/CRP•LFTs•U&Es
-Obstructive nephropathy, hypercalcaemia•Serology
-HIV, HTLV-1, HCV•Imaging
-CXR-Intrathoracic lymphadenopathy, mediastinal expansion-CT-Thorax, abdomen for staging-Bone scan-PET-MRI- Brain, cord-USS- Scrotum
•BM biopsy-Should always be carried out
![Page 78: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/78.jpg)
•Lymph node USS and excision biopsy
![Page 79: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/79.jpg)
Treatment•Low grade
-Localised (rare)- radiotherapy, surgery-Disseminated- watch and wait or chemo when symptomatic/organ dysfunction-Gastric MALT- associated with H pylori, antibiotic therapy curative in 90%
•High grade-Aggressive chemo e.g. CHOP-Maintenance not needed-Allogenic stem cell transplantation-CNS prophylaxis in very high grade e.g. Burkitt’s
![Page 80: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/80.jpg)
Prognosis of lymphoma
5 year survival rates•Hodgkin’s- highly curable
-I/II- 90%-IV- 65%-Long-term sequelae of treatment
•Non-Hodgkin’s- vary widely (see IPI)-Overall 63%-Indolent follicular lymphoma I/II- 91% but may not be curable-DLBLC- curable with aggressive chemo
![Page 81: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/81.jpg)
Terminally differentiated cells vs Partially differentiated
Plasma cell neoplasm e.g. Multiple myeloma and Waldenstrom’s macroglobulinaemia
![Page 82: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/82.jpg)
• Multiple Myeloma• MGUS• Waldenstrom’s macroglobulinaemia• (Non-Hodgkin lymphoma)• (CLL)
![Page 83: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/83.jpg)
• Presdisposing factors– Radiation– Benzene– Pesticides
• Epidemiology– 4 per 100,000 per year– Median age 66 years
• Pathophysiology– Post germinal centre B cell proliferation
• Monoclonal antibody
![Page 84: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/84.jpg)
![Page 85: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/85.jpg)
• Hypercalcaemia• Renal impairment• Anaemia• Bone disease
• Hyperviscosity• Amyloidosis (AL)• Infection (recurrent)
![Page 86: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/86.jpg)
![Page 87: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/87.jpg)
• Amyloid L – Ig light chains– paraproteinaemias
• Amyloid A – Protein A– Chronic inflammation
• Amyloid TTR – Transthyretin– Transthyretin abnormality
• Polyneuropathy,• Restrictive cardiomyopathy
• Amyloid B2M – Beta 2 microglobulin– Occurs in dialysis
• Carpal tunnel
• Also associated with Alzheimer’s disease, Diabetes Mellitus
![Page 88: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/88.jpg)
• FBC and film• ESR• Urine dipstick• 24 hour urine collection• U&Es• Urate• Albumin, calcium, phosphate, ALP• Serum and urinary electrophoresis• Serum Ig• X-ray• (BM Biopsy –diagnostic rather than screening)
![Page 89: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/89.jpg)
1. Production of a single monoclonal antibody (paraprotein)– ‘M’ band in γglobulin region on serum/ urine
electrophoresis2.Increased clonal plasma cells in the bone
marrow– >20% monoclonal plasma cells on bone marrow
biopsy3. Evidence of organ damage (‘CRAB HAI’)
![Page 90: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/90.jpg)
• Prognosis– MM remains an incurable disease– Mean survival 3-4 yrs from diagnosis
• Treatment– Specific– Supportive
![Page 91: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/91.jpg)
• Intensive or non intensive– Intensive if <65– Non intensive if >65
• Intensive– 4-6 cycles chemotherapy
• Cyclophosphamide, dexamethasone, thalidomide– THEN autologous stem cell collection and
transplant• Non-intensive
– Chemo: Melphalan and cyclophosphamide
![Page 92: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/92.jpg)
• Renal disease– rehydration – 3L/day
• Bone disease– Bisphosphonates– Radiotherapy to bony lesions– Corticosteroids
• Anaemia– Transfusion/ EPO
• Hyperviscosity– Plasmapheresis
• Infection– Broad spectrum Abx and antifungals
![Page 93: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/93.jpg)
• Post germinal centre B cell proliferation• Monoclonal antibody/ paraprotein production
– M Band– BJP
• >20% monoclonal plasma cells in BM• ‘CRAB HAI’• Specific and supportive treatment• Outcome still poor
![Page 94: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/94.jpg)
• Often discovered incidentally in elderly• Benign• Characterised by:
– Low levels of paraprotein, normal levels of Ig– <10% plasma cells in bone marrow– Absence of lytic bone lesions– Absent/minimal urinary BJP– Absence of end organ damage associated with MM
• 1% per year develop MM
![Page 95: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/95.jpg)
• Lymphoplasmacytoid proliferation– Similarities with CLL
• IgM paraprotein– Plasma viscosity
• Organomegaly and lymphadenopathy more common than in MM– No end organ damage (cf MM)
![Page 96: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/96.jpg)
![Page 97: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/97.jpg)
A 67 year old lady is found to have an Hb of 18.9g/dL. Her erythropoeitin level is markedly raised. Which of the following is the least likely diagnosis?
A) COPDB) Eisenmenger’s syndromeC) Polycythaemia veraD) Renal cell carcinomaE) Nepalese woman living at high altitude
![Page 98: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/98.jpg)
A 67 year old lady is found to have an Hb of 18.9g/dL. Her erythropoeitin level is markedly raised. Which of the following is the least likely diagnosis?
A) COPDB) Eisenmenger’s syndromeC) Polycythaemia veraD) Renal cell carcinomaE) Nepalese woman living at high altitude
![Page 99: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/99.jpg)
Which one of the following is not consistent with a diagnosis of MGUS?
A) normal urinalysisB) normal renal functionC) 20% plasma cells in bone marrowD) Normochromic, normocytic anaemia with Rouleaux formationsE) Absence of lytic bone lesions
![Page 100: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/100.jpg)
Which one of the following is not consistent with a diagnosis of MGUS?
A) normal urinalysisB) normal renal functionC) 20% plasma cells in bone marrowD) Normochromic, normocytic anaemia with Rouleaux formationsE) Absence of lytic bone lesions
![Page 101: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/101.jpg)
A patient has a sharp M band on serum electrophoresis. Which of the following is least consistent with this result?
A) IgG MMB) Waldenstrom’ macroglobulinaemiaC) AA amyloidosisD) MGUSE) CLL
![Page 102: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/102.jpg)
A patient has a sharp M band on serum electrophoresis. Which of the following is least consistent with this result?
A) IgG MMB) Waldenstrom’ macroglobulinaemiaC) AA amyloidosisD) MGUSE) CLL
![Page 103: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/103.jpg)
Which ONE of these is the most likely clinical presentation of a child with acute lymphoblastic leukaemia?
a) A 6 month history of fatigue and repeated upper respiratory tract infectionb) Poor appetite and abdominal pain resulting from swollen spleenc) Swollen gums in the mouthd) Recent history of bruising and tirednesse) None- incidental finding
![Page 104: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/104.jpg)
Which ONE of these is the most likely clinical presentation of a child with acute lymphoblastic leukaemia?
a) A 6 month history of fatigue and repeated upper respiratory tract infectionb) Poor appetite and abdominal pain resulting from swollen spleenc) Swollen gums in the mouthd) Recent history of bruising and tirednesse) None- incidental finding
![Page 105: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/105.jpg)
A blood smear of a patients shows increased numbers of neutrophils, eosinophils and basophils. In addition, there are increased numbers of promyelocytes (but infrequent blast cells). What is the optimum treatment for this patient?
a)Allogenic stem cell transplantationb)Combination chemoc) Imatinibd)Blood transfusion to relieve symptomse)Rifampicin and isoniazid
![Page 106: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/106.jpg)
A blood smear of a patients shows increased numbers of neutrophils, eosinophils and basophils. In addition, there are increased numbers of promyelocytes (but infrequent blast cells). What is the optimum treatment for this patient?
a)Allogenic stem cell transplantationb)Combination chemoc) Imatinibd)Blood transfusion to relieve symptomse)Rifampicin and isoniazid
![Page 107: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/107.jpg)
A 59 year old man receiving chemotherapy for NonHodgkin’s Lymphoma develops painful haematuria. Which of the following is the most likely cause of his symptoms?
A) RituximabB) CyclophosphamideC) Adriamycin (doxorubicin/ hydroxydaunarubicin)D) Vincristine (oncovin)E) Prednisolone
![Page 108: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/108.jpg)
A 59 year old man receiving chemotherapy for NonHodgkin’s Lymphoma develops painful haematuria. Which of the following is the most likely cause of his symptoms?
A) RituximabB) CyclophosphamideC) Adriamycin (doxorubicin/ hydroxydaunarubicin)D) Vincristine (oncovin)E) Prednisolone
![Page 109: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/109.jpg)
A 50 year old woman is about to commence chemotherapy for treatment of AML. Which of the following medications should she be started on prior to chemotherapy?
A) ColchicineB) DexamethasoneC) DiclofenacD) AllopurinolE) Hydroxychloroquine
![Page 110: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/110.jpg)
A 50 year old woman is about to commence chemotherapy for treatment of AML. Which of the following medications should she be started on prior to chemotherapy?
A) ColchicineB) DexamethasoneC) DiclofenacD) AllopurinolE) Hydroxychloroquine
![Page 111: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/111.jpg)
A 6 year old boy from Kenya develops swelling of the jaw. The mass responds rapidly to chemotherapy. What is the most likely diagnosis?
a) Burkitt's lymphomab) Follicular lymphomac) Mycosis fungoidesd) Lymphoblastic lymphomae) Enteropathy-associated T cell lymphoma
![Page 112: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/112.jpg)
A 6 year old boy from Kenya develops swelling of the jaw. The mass responds rapidly to chemotherapy. What is the most likely diagnosis?
a) Burkitt's lymphomab) Follicular lymphomac) Mycosis fungoidesd) Lymphoblastic lymphomae) Enteropathy-associated T cell lymphoma
![Page 113: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/113.jpg)
A 22-year-old man presents with fever, sweating, particularly at night, pruritus and weight loss.
O/E: palpable, painless cervical lymph nodes and no skin manifestations. The most appropriate investigation would be:-
a) FBCb) Lymph Node Biopsyc) Chest Radiographd) CT scan of the neck and mediastinume) Mantoux Test
![Page 114: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/114.jpg)
A 22-year-old man presents with fever, sweating, particularly at night, pruritus and weight loss.
O/E: palpable, painless cervical lymph nodes and no skin manifestations. The most appropriate investigation would be:-
a) FBCb) Lymph Node Biopsyc) Chest Radiographd) CT scan of the neck and mediastinume) Mantoux Test
![Page 115: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/115.jpg)
25-year-old woman presents with a single, non-tender, enlarged cervical lymph node. She also complains of fever and night sweats. Lymph node biopsy reveals infiltration with histiocytes and lymphocytes and presence of cells with bilobed mirror-image nuclei. The most likely diagnosis is:-
a) Non-Hodgkin’s lymphomab) Hodkin’s lymphomac) Sarcoidosisd) Acute Lymphoblastic Leukemia (ALL)e) TB
![Page 116: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/116.jpg)
25-year-old woman presents with a single, non-tender, enlarged cervical lymph node. She also complains of fever and night sweats. Lymph node biopsy reveals infiltration with histiocytes and lymphocytes and presence of cells with bilobed mirror-image nuclei. The most likely diagnosis is:-
a) Non-Hodgkin’s lymphomab) Hodkin’s lymphomac) Sarcoidosisd) Acute Lymphoblastic Leukemia (ALL)e) TB
![Page 117: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/117.jpg)
30-year-old man has had a progressively worsening productive cough for one month. On physical examination, a few small non-tender lymph nodes are palpable in the axillae, and the tip of the spleen is palpable.
Hb 10.2 g/dl, Hct 31.1% MCV 90 fL, WBC count 67 x 10 9 / L Platelet count 36 x 10 9 / L.
Microscopic examination of his peripheral blood smear shows many blasts with Auer rods. Which of the following is the most likely diagnosis?
A) Leukemoid reaction B) Acute myelogenous leukemia C) Chronic lymphocytic leukemia D) Acute lymphoblastic leukemia E) Leukoerythroblastosis
![Page 118: Haematology Tutorial](https://reader034.vdocuments.net/reader034/viewer/2022050806/58efc3471a28ab45228b463b/html5/thumbnails/118.jpg)
30-year-old man has had a progressively worsening productive cough for one month. On physical examination, a few small non-tender lymph nodes are palpable in the axillae, and the tip of the spleen is palpable.
Hb 10.2 g/dl, Hct 31.1% MCV 90 fL, WBC count 67 x 10 9 / L Platelet count 36 x 10 9 / L.
Microscopic examination of his peripheral blood smear shows many blasts with Auer rods. Which of the following is the most likely diagnosis?
A) Leukemoid reaction B) Acute myelogenous leukemia C) Chronic lymphocytic leukemia D) Acute lymphoblastic leukemia E) Leukoerythroblastosis